BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27261882)

  • 1. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
    Illing PT; Mifsud NA; Purcell AW
    Curr Opin Immunol; 2016 Oct; 42():31-40. PubMed ID: 27261882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-mediated hypersensitivity reactions to drugs.
    Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
    Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and Delayed Drug-Induced Hypersensitivity.
    Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
    Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.
    Sullivan A; Watkinson J; Waddington J; Park BK; Naisbitt DJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):261-274. PubMed ID: 29460640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic predispositions in drug allergy: the role of HLA].
    Bergmann MM; Villard J; Caubet JC
    Rev Med Suisse; 2014 Apr; 10(426):864-8. PubMed ID: 24834645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
    Martin AM; Nolan D; Gaudieri S; Almeida CA; Nolan R; James I; Carvalho F; Phillips E; Christiansen FT; Purcell AW; McCluskey J; Mallal S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4180-5. PubMed ID: 15024131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
    Aoki S
    Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
    Yun J; Adam J; Yerly D; Pichler WJ
    Allergy; 2012 Nov; 67(11):1338-46. PubMed ID: 22943588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen-associated drug hypersensitivity.
    Illing PT; Vivian JP; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2013 Feb; 25(1):81-9. PubMed ID: 23141566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune pathomechanism of drug hypersensitivity reactions.
    Pichler WJ; Naisbitt DJ; Park BK
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
    Deshpande P; Hertzman RJ; Palubinsky AM; Giles JB; Karnes JH; Gibson A; Phillips EJ
    Clin Pharmacol Ther; 2021 Sep; 110(3):607-615. PubMed ID: 34143437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLAs: Key regulators of T-cell-mediated drug hypersensitivity.
    Redwood AJ; Pavlos RK; White KD; Phillips EJ
    HLA; 2018 Jan; 91(1):3-16. PubMed ID: 29171940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions.
    Schutte RJ; Sun Y; Li D; Zhang F; Ostrov DA
    Clin Lab Med; 2018 Dec; 38(4):669-677. PubMed ID: 30420060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan.
    Sun HY; Hung CC; Lin PH; Chang SF; Yang CY; Chang SY; Chang SC
    J Antimicrob Chemother; 2007 Sep; 60(3):599-604. PubMed ID: 17631508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.